BioMedTracker is part of the Pharma intelligence division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
2/5/16 Bristol-Myers Squibb (BMY) Daklinza for Hepatitis C (HCV) (Antiviral) Subscribers Only Subscribers Only Subscribers Only
2/5/16 Johnson & Johnson (JNJ) Xarelto for Stroke Prevention in Atrial Fibrillation (SPAF) Subscribers Only Subscribers Only Subscribers Only
2/5/16 Immunomedics (IMMU) Sacituzumab Govitecan for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
2/5/16 Amgen (AMGN) Repatha for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only Subscribers Only
2/5/16 Vertex (VRTX) Kalydeco for Cystic Fibrosis (CF) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
02/05/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
02/07/16 Subscribers Only Subscribers Only Trial Data - Updated Results
02/08/16 Subscribers Only Subscribers Only Company - Earnings Announcement
02/08/16 Subscribers Only Subscribers Only Company - Earnings Announcement
02/08/16 Subscribers Only Subscribers Only Company - Earnings Announcement